(Q30619368)

25 June 2017

1 reference

title

Human lung deposition data: the bridge between in vitro and clinical evaluations for inhaled drug products? (English)

1 reference

25 June 2017

Newman SP

1

1 reference

25 June 2017

Wilding IR

series ordinal

2

1 reference

25 June 2017

Hirst PH

series ordinal

3

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

International Journal of Pharmaceutics

25 June 2017

published in

1 reference

25 June 2017

volume

208

1 reference

25 June 2017

issue

1-2

1 reference

25 June 2017

page(s)

49-60

1 reference

Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Respiratory tract deposition of sodium cromoglycate is highly dependent upon technique of inhalation using the Spinhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

In vivo characterization of inhaled pharmaceuticals using quantitative positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

The inhalation device influences lung deposition and bronchodilating effect of terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Drug delivery via the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Medical Aerosol Inhalers: Past, Present, and Future

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Determination of the relative bioavailability of salbutamol to the lung following inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Characteristics of radiolabelled versus unlabelled inhaler formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Imaging techniques for assessing drug delivery in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Scintigraphic comparison of budesonide deposition from two dry powder inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

How to use a rotahaler

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

A new method of quantification of the pulmonary regional distribution of aerosols using combined CT and SPECT and its application to nedocromil sodium administered by metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Determining equivalence of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at Royal Brompton National Heart & Lung Institute, London 24 June 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Delivery of fenoterol via Respimat, a novel 'soft mist' inhaler. a randomised, double-blind (within device), placebo-controlled, cross-over, dose-ranging study in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2800%2900538-X

7 January 2021

10.1016/S0378-5173(00)00538-X

Identifiers

DOI

1 reference

25 June 2017

1 reference